Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Moon, Ju-Yeon | - |
dc.contributor.author | Kang, Se Mi | - |
dc.contributor.author | Lee, Jeongae | - |
dc.contributor.author | Cho, Joo-Youn | - |
dc.contributor.author | Moon, Myeong Hee | - |
dc.contributor.author | Jang, In-Jin | - |
dc.contributor.author | Chung, Bong Chul | - |
dc.contributor.author | Choi, Man Ho | - |
dc.date.accessioned | 2024-01-20T12:00:53Z | - |
dc.date.available | 2024-01-20T12:00:53Z | - |
dc.date.created | 2021-09-05 | - |
dc.date.issued | 2013-08 | - |
dc.identifier.issn | 0163-4356 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/127818 | - |
dc.description.abstract | Background: Drug-induced cytochrome P450 (CYP) activity affects endocrine function and drug clearance rates, leading to the development of unpredictable pathologic and toxicologic risks.Methods: Urinary steroid profiling based on gas chromatography-mass spectrometry (GC-MS) was used for simultaneous quantification of CYP-mediated regioselective hydroxysteroids and their substrates, including 26 androgens, 9 estrogens, 5 progestins, and 7 corticoids. The quantitative data were visualized using a hierarchically clustered heat map to allow identification of CYP-mediated steroid signatures. Twelve healthy subjects were orally administered 600 mg of rifampicin a day for 7 days, and their CYP enzyme activity was evaluated.Results: Using GC-MS, all 47 steroids were well separated with good peak shapes. This assay had good linearity (r(2) > 0.994) in a dynamic range, and the interassay imprecision (% CV) and inaccuracy (% bias) were 3.0%-15.6% and 98.0%-109.2%, respectively. Administration of the CYP3A4 inducer rifampicin produced distinct differences in CYP3A4 and CYP11B1, CYP19A1, HSD11B, and HSD17B, which were indicated by their heat map-visualized steroid signatures.Conclusions: This CYP-mediated steroid signature profile allows simultaneous assessment of CYP1A, CYP1B, CYP2C, CYP3A, CYP11B, CYP17A, CYP19A, and CYP21A in urine samples. This method could therefore be a useful tool for assessing drug efficacy. | - |
dc.language | English | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.subject | PREGNANE-X-RECEPTOR | - |
dc.subject | MASS-SPECTROMETRY | - |
dc.subject | URINARY 6-BETA-HYDROXYCORTISOL | - |
dc.subject | POSTMENOPAUSAL WOMEN | - |
dc.subject | METABOLISM | - |
dc.subject | HYDROXYLATION | - |
dc.subject | TESTOSTERONE | - |
dc.subject | ASSAYS | - |
dc.subject | CYP3A | - |
dc.subject | 4-HYDROXYANDROSTENEDIONE | - |
dc.title | GC-MS-Based Quantitative Signatures of Cytochrome P450-Mediated Steroid Oxidation Induced by Rifampicin | - |
dc.type | Article | - |
dc.identifier.doi | 10.1097/FTD.0b013e318286ee02 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | THERAPEUTIC DRUG MONITORING, v.35, no.4, pp.473 - 484 | - |
dc.citation.title | THERAPEUTIC DRUG MONITORING | - |
dc.citation.volume | 35 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 473 | - |
dc.citation.endPage | 484 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000322202600007 | - |
dc.identifier.scopusid | 2-s2.0-84880570391 | - |
dc.relation.journalWebOfScienceCategory | Medical Laboratory Technology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.relation.journalResearchArea | Medical Laboratory Technology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | PREGNANE-X-RECEPTOR | - |
dc.subject.keywordPlus | MASS-SPECTROMETRY | - |
dc.subject.keywordPlus | URINARY 6-BETA-HYDROXYCORTISOL | - |
dc.subject.keywordPlus | POSTMENOPAUSAL WOMEN | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.subject.keywordPlus | HYDROXYLATION | - |
dc.subject.keywordPlus | TESTOSTERONE | - |
dc.subject.keywordPlus | ASSAYS | - |
dc.subject.keywordPlus | CYP3A | - |
dc.subject.keywordPlus | 4-HYDROXYANDROSTENEDIONE | - |
dc.subject.keywordAuthor | cytochrome P450 | - |
dc.subject.keywordAuthor | steroid hydroxylation | - |
dc.subject.keywordAuthor | GC-MS | - |
dc.subject.keywordAuthor | steroid signatures | - |
dc.subject.keywordAuthor | rifampicin | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.